ATC Group: D01AC02 Miconazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01AC02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use
4 D01AC Imidazole and triazole derivatives
5 D01AC02 Miconazole

Active ingredients in D01AC02

Active Ingredient

Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.

Related product monographs

Document Type Information Source  
 CANDIPLAS Cream MPI, EU: SmPC Υπουργείο Υγείας (CY)
 DAKTARIN Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAKTARIN Oral gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 GYNO-DAKTARIN Vaginal cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.